Live Breaking News & Updates on Limmatech biologics

LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections

SCHLIEREN, Switzerland, October 09, 2023 LimmaTech Biologics AG today announced the closing of a USD 37 million (CHF 33 million) Series A financing round co-led by Adjuvant Capital, AXA IM Alts, and the Novo Holdings REPAIR Impact Fund. The proceeds will enable LimmaTech to advance its proprietary technology platform and accelerate its pipeline of preclinical and clinical vaccine candidates against increasingly dangerous bacterial infections, including programs addressing shigellosis and gonorr

United-states , New-york , Switzerland , London , City-of , United-kingdom , Alexander-siebert , Kabeer-aziz , Zina-affas-besse , Limmatech-biologics , Franz-werner-haas , Camilla-petrycer-hansen

LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidru

SCHLIEREN, Switzerland (BUSINESS WIRE) LimmaTech Biologics AG today announced the closing of a USD 37 million (CHF 33 million) Series A financing round co-led by Adjuvant Capital, AXA IM Alts, and the Novo Holdings REPAIR Impact Fund. The proceeds will enable LimmaTech to advance its proprietary technology platfor.

United-states , New-york , London , City-of , United-kingdom , Zina-affas-besse , Camilla-petrycer-hansen , Kabeer-aziz , Limmatech-bio , Alexander-siebert , Hooft-van-huijsduijnen , Franz-werner-haas

LimmaTech Biologics AG: LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections

LimmaTech Biologics AG: LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states , New-york , London , City-of , United-kingdom , Zina-affas-besse , Hooft-van-huijsduijnen , Camilla-petrycer-hansen , Alexander-siebert , Franz-werner-haas , Limmatech-bio , Limmatech-biologics

LimmaTech Biologics Raises $37M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Switzerland , Limmatech-biologics , Kabeer-aziz , Camilla-petrycer-hansen , Zina-affas-besse , Franz-werner-haas , Novo-holdings , Impact-fund , Adjuvant-capital ,

GSK raises financial guidance while Thermo Fisher slashes full-year forecast

The crowning achievement of the quarter for GSK was the Food and Drug Administration’s approval of Arexvy, the first vaccine for RSV.

China , United-kingdom , British , Dame-emma-walmsley , Marc-casper , Limmatech-biologics , Completion-of-the-bellus-health , Thermo-fisher , Drug-administration , Emma-walmsley , Bellus-health , Audax-private-equity

GSK Grants LimmaTech Biologics License to Develop and Commercialize Shigella Vaccine

GSK Grants LimmaTech Biologics License to Develop and Commercialize Shigella Vaccine
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Switzerland , Swiss , Patricia-martin , Paul-wolfrom , Limmatech-biologics , Thomas-breuer , Alexander-siebert , Limmatech-bio , Global-health , Wellcome , Regulatory-affairs-at-limmatech-bio , Trophic-communications

LimmaTech Biologics Appoints Franz-Werner Haas as CEO to Lead Company into Next Stage of Corporate Growth

LimmaTech Biologics Appoints Franz-Werner Haas as CEO to Lead Company into Next Stage of Corporate Growth
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Franz-werner-haas , Limmatech-biologics , Limmatech-bio , Alexander-siebert , Philippe-dro , University-of-edinburgh , Trophic-communications , Catholic-university-of-leuven , University-of-saarbruecken , Chief-executive , Chief-corporate-officer , Chief-operating

LimmaTech Biologics Appoints Franz-Werner Haas as CEO to Lead Company into Next Stage of Corporate G

LimmaTech has leveraged a novel technology platform to produce a pipeline of vaccines against multi-resistant bacterial infections that present global health threatsSCHLIEREN, Switzerland (BUSINESS WIRE) LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threate.

Limmatech-bio , Franz-werner-haas , Alexander-siebert , Limmatech-biologics , Philippe-dro , Trophic-communications , Catholic-university-of-leuven , University-of-saarbruecken , University-of-edinburgh , Chief-executive , Chief-corporate-officer , Chief-operating

Swiss startup LimmaTech licenses GSK vaccine, hires ex-CureVac chief as CEO

BioPharma

China , Switzerland , Kenya , Chinese , Swiss , Franz-werner-haas , Glaxosmithkline , Wellcome , World-health-organization , Dive-brief , Limmatech-biologics ,

GSK signs in-license agreement with LimmaTech for shigella vax candidate

LimmaTech also named Franz-Werner Haas as its CEO.

Switzerland , Swiss , Franz-werner-haas , Limmatech-biologics , Thomas-breuer , Wellcome , Sirona-dental-systems , Centers-for-disease , Wellcome-trust , Disease-control , Lion-bioscience ,